Title: Spectrum of Biopsy Proven Renal Diseases (BPRD): A Single Center Experience
Authors: Lakshminarayana GR, Indu S, Seethalekshmy NV, Ranjit N, Biju MV
DOI: http://dx.doi.org/10.18535/jmscr/v4i4.15
Kidney biopsy is one of the most important tools in the assessment of kidney disease as histopathological diagnosis promotes evidence based practice in Nephrology. This is a study was done by including all consecutive percutaneous kidney biopsies (273; Males:147, Females: 126) performed at EMS Memorial Cooperative Hospital, Perinthalmanna, Kerala, India, from September 2009 to February 2016. Among the biopsy proven renal diseases (BPRD); primary glomerular diseases (PGD) were the commonest (78.39%) followed by secondary glomerular diseases (SGD) (12.45%) and tubulointerstitial diseases (TID) (9.16%). The IgA Nephropathy (IgAN) was the commonest PGD and majority had mesangial hypercellularity (M1) (93.54%), tubular atrophy (T1 or T2 67.74%) and the most common pattern was M1, E0, S0, T1, suggesting that patients of Indian subcontinent have aggressive disease type; unlike western literature. The focal segmental glomerulosclerosis (FSGS) was the second commonest PGD and majority were of not otherwise specified (NOS) type. FSGS, membranous nephropathy (MN) and minimal change disease (MCD) were the 3 most common causes for PGD causing nephrotic syndrome. Diabetic nephropathy and lupus nephritis (LN) were the two most common biopsy proven SGD. Among the patients of diabetes mellitus (DM) who underwent renal biopsy with suspicion of non-diabetic renal disease (NDRD); 58.33% had NDRD, 16.67% had DN+ NDRD and 25% had DN alone. This study the changing pattern BPRD in comparison to earlier studies. This study also, confirms the aggressive nature of IgAN in Indian patients and underlines the importance of renal biopsy in patients of DM. Key Words: Renal biopsy, primary glomerular diseases, secondary glomerular diseases, Oxford-MEST classification, 1. Prasad N, Kumar S, Manjunath R, Bhadauria D, Kaul A, Sharma RK, et al. Real-time ultrasound-guided percutaneous renal biopsy with needle guide by nephrologists decreases post-biopsy complications.Clin Kidney J. 2015;8(2):151-156. DOI: 10.1093/ckj/sfv012. 2. Srija M, Lakshminarayana G, Anil M, Rajesh R, Kurian G, Unni VN. Pattern of renal diseases on kidney biopsies at a tertiary care hospital in Kerala. Amrita Journal of Medicine 2011; 7 (1): 32-39. 3. Ramesh CV, Ravi KM, Prasad G. Spectrum of biopsy proven renal disease – referral hospital experience in a developing nation: Analysis based on 624 renal biopsies. International Journal of Science and Research (IJSR) 2014; 4 (4): 704-708. 4. Narasimhan B, Chacko B, John GT, Korula A, Kirubakaran MG, Jacob CK. Characterization of kidney lesions in Indian adults: towards a renal biopsy registry.J Nephrol. 2006 Mar-Apr;19(2):205-210. 5. Jayakumar J, Sushanth K, Mohammed K, Chakrapani M. Pattern of glomerular diseases in a tertiary care center in south India: A prospective study. Saudi J Kidney Dis Transpl 2013;24(1):168-171. 6. Clement WD, Vijaya MV Gireesh MS, Mahesh E, Gurudev KC, Radhika K. Review of renal biopsy database: a single centre south Indian study.Int J Med Res Health Sci.2014;3(4):959-966. 7. Sunita S, Nisha M, Rajeev S, Monika S, Renuka V, Megha R. Profile of renal biopsies in a tertiary care hospital. International J. of Healthcare and Biomedical Research 2014; 2 (3): 53-59. 8. Das U, Dakshinamurty KV, Prayaga A. Pattern of biopsy-proven renal disease in a single center of south India: 19 years’ experience. Indian J Nephrol 2011; 21:250-257. 9. Neha M, Kusum J, Swapnil R, Ritambhra N, Vinay S.Primary IgA nephropathy in north India: is it different? Postgrad Med J 2011;88 (1035): 15-20.DOI:10.1136/postgradmedj-2011-130077. 10. Hamid N, Mojgan M, Ali G, Heshmatollah S, Soleiman K, Azar B, et al. Oxford-MEST classification in IgA nephropathy patients: A report from Iran. J Nephropathology. 2012; 1(1):31-42. DOI: 10.5812/jnp.7. 11. Maria FS, Caldas MLR, Dos‑Santos WLC, Sementilli A, Furtado P, Araújo S, Pegas KL, Petterle RR, and Franco MF. IgA nephropathy in Brazil: apropos of 600 cases.SpringerPlus 2015; 4:547. DOI 10.1186/s40064-015-1323-x. 12. Vanikar AV, Kanodia KV, Patel RD, Trivedi HL.Primary Immunoglobulin A (IgA) nephropathyin Western India. Indian J Nephrol 2005;15: 227-231. 13. Sanjay D, Satyam SJ, Rakesh G. Original Article - Study of Etiological Profile of Nephrotic Syndrome in Adults. International Journal of Applied Research 2015; 1(9): 545-549. 14. Vishal G, Mayuri T, Anila AK, Dipankar S, Arpita R, Rajendra P.Spectrum of nephrotic syndrome in adults: Clinicopathological study from a single center in India. Renal Failure 2013; 35 (4): 487-491. DOI: 10.3109/0886022X.2013.768939. 15. Deepa G, Vikas C. Clinicopathological study of nephrotic syndrome in adults. Journal of Evidence Based Medicine and Healthcare 2015; 2 (49): 8518-8520, DOI: 10.18410/jebmh/2015/1168. 16. Li Z, Wenwen R, Wenge L, Guming Z, Jianhua L. Evaluation of renal biopsies in type 2 diabetic patients with kidney disease: A clinicopathological study of 216 cases. International Urology and Nephrology 2013; 45 (1): 173-179. 17. Chien-Pin L, Chia-Chu C, Yu Y, Yau-Ko W, Pin-Fang C, Mei-ling C, Kun-Tu Y, Yet-Ming L.Non-diabetic renal diseases in type 2 diabetic patientswith renal involvement: Clinicopathological study in asingle medical center in Taiwan. ActaNephrologica 2010; 24: 157-166. 18. Prakash J. Non-diabetic renal disease (NDRD) in patients with type 2 diabetes mellitus (Type 2 DM).J Assoc Physicians India. 2013;61(3):194-199. 19. Das U, Dakshinamurty KV, Prayaga V, Uppin MS. Nondiabetic kidney disease in type 2 diabetic patients: A single center experience. Indian J Nephrol. 2012; 22(5): 358–362. DOI: 10.4103/0971-4065.103912. Abstract
References